Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delmopinol for peri-implant mucositis
2014-004825-42Phase 4Completed
- Sponsor
- Academic Centre for Dentistry in Amsterdam
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of delmopinol in peri-implant mucositis (3 arms), sponsored by Academic Centre for Dentistry in Amsterdam. Primary endpoint: Resolution of peri-implant mucosal inflammation. Started Nov 2016; status: completed.
02
Drugs
delmopinol
03
Conditions
peri-implant mucositis
Beyond the preview
Go deeper on 2014-004825-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004825-42.